| |
|
Liver
Cancer
Clinical
evaluation of integration of transcatheter arterial chemoembolization and
traditional Chinese medicine in treating metastatic liver cancer
1: Zhong Xi Yi Jie
He Xue Bao. 2003 Sep;1(3):187-8, 233. Related Articles, Links
[Article in Chinese]
Meng ZQ, Xu YY, Liu LM, Song MZ, Huang
WX.
Department of
Traditional Chinese Medicine, Cancer Hospital, Fudan University, Shanghai
200032, China. mengzhq@sina.com
OBJECTIVE: To
evaluate the treatment effect, quality of life and side-effect of transcatheter
arterial chemoembolization (TACE) and traditional Chinese medicine (TCM) in
treating metastatic liver cancer.
|
|
|
|
METHODS:
Thirty-nine cases of colon metastatic liver cancer were randomly divided into
two groups. Both TACE and TCM were used in the treatment group, while only TACE
was used in the control group. The drug used in TACE included floxuridine,
pirarubicin, cisplatin, and the herbs for strengthening the spleen and
regulating Qi were used in TCM.
RESULTS: The
response rate in the treatment group was 30% (45% including minor remission
patients), and the median survival time was 18.6 months. While in the control
group the response rate was 15.8% (36.8% including minor remission patients),
and the median survival time was 14.3 months. The 1-, 2-, 3- year survival rates
of treatment group and the control group were 70.2%, 40.3%, 13.0% and 68.7%,
29.5%, 10.3% respectively. There were fewer other organ metastases in the
treatment group. The score from the EORTC quality of life questionnaire QLQ-C30
in treatment group was higher than that in the control group.
CONCLUSION:
Integration of TACE and TCM in treating colon metastatic liver cancer has better
results.
|
|
|
